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Summary
Background:

Material/Methods:

Previous clinical studies have not examined the relationship between nicotine abstinence and opioid use for postoperative analgesia. This may be important because tobacco smokers are routinely required to abstain from smoking just before and during acute post-surgical recovery. This study investigated IV morphine self-administration [patient controlled analgesia (PCA)], subjective pain/drug
effects and other measures during post-operative (elective Cesarean section) recovery.
Seven females, selected to vary in nicotine use [4 non-using controls (CON), 3 users (NIC)], completed the protocol. Gender, time and type of surgery, and pre- and intra-operative medications
were controlled. Subject assessments included the McGill Pain Questionnaire and the Proﬁle of
Mood States; drug effects were measured using the Addiction Research Center Inventory.

Results:

Mean (M ±SD) 24-hr morphine responding (button-pressing requests) was signiﬁcantly higher for
NIC (M=183±50) than CON (M=38±10). Weight-adjusted morphine use (mg/kg/24 hr) was signiﬁcantly higher for NIC (M=1.80±0.23) than CON (M=0.64±0.14). Although the groups reported similar pain severity following morphine loading, NIC patients reported signiﬁcantly greater
pain severity than CON patients after 24 hr PCA.

Conclusions:

These preliminary data suggest that a history of nicotine use and/or short-term nicotine abstinence
can modulate morphine use and analgesia during post-operative recovery. These procedures provide
a model for studying patterns and determinants of analgesic self-administration in medical settings.
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BACKGROUND

MATERIAL AND METHODS

About 25% of the population of the United States
are smokers and cannot smoke while hospitalized.
Furthermore, there has been renewed emphasis on assessment and adequate treatment of pain in hospital settings. Therefore, there is a pressing need to understand
whether and to what degree cigarette smokers (presumably due to nicotine abstinence during hospital stays)
are at increased risk for post-surgical pain. If such a risk
were demonstrated, then physicians could use smoking
as a marker to address the special analgesic needs of this
patient population.

Participants

Patient Controlled Analgesia (PCA) is a safe and effective treatment for acute post-surgical pain. PCA allows the patient to self-administer analgesics (typically intravenous opioids) using limited-access schedules
under medical supervision. Relative to traditional ondemand treatment (in which the patient must request
medical staff to administer the analgesic), PCA is associated with superior analgesia, more rapid recovery, fewer side effects, and greater patient satisfaction. Patient
satisfaction using PCA is related to resting pain levels, preoperative distress, and balancing the number
of responses needed to obtain pain relief versus side
effects [1–3].
Previous clinical studies have not examined the relationship between nicotine abstinence and opioid use for postoperative analgesia. This may be important because tobacco smokers are routinely required to abstain from
smoking just before and during acute post-surgical recovery. To our knowledge, there are no prospective, controlled clinical studies that have examined whether patients
with different nicotine use/abstinence histories differentially self-administer opioids. A retrospective study did
show that female smokers use more narcotic post-operatively than did females who never smoked [4]. Tolerance
to nicotine-induced analgesia develops during its chronic administration and abstinence from nicotine can increase nociception [5,6].
In the present study, we examined individual differences in IV morphine use (PCA) and analgesia among postCesarean section patients who varied in nicotine use [4
controls with no lifetime nicotine use (CON) vs. 3 current nicotine users (NIC)]. Salient variables (gender,
type and duration of surgery, and pre- and intra-operative medications) were controlled in this study. The hypothesis was that morphine self-administration would
be greater among patients with tobacco use histories
who were nicotine-abstinent during hospitalization for
their surgery. Pain measures were also evaluated to assess whether pain scores increased along with the predicted morphine utilization. Button-pressing responses
(recorded by the PCA pump) and morphine use (actual drug deliveries) may be influenced by several factors;
however, only nicotine use and abstinence were examined in this study. The post-surgical time course of morphine responding and self-administration was compared
with concurrent self-reported pain and mood, observerrated pain behavior and side effects, vital signs, and psychomotor performance.
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The local Institutional Review Board approved this study
and all participants (n=10) gave written informed consent. Women scheduled to undergo elective Cesarean section at the Johns Hopkins Bayview Medical Center were
eligible for this study. Exclusion criteria were: emergency Cesarean section, medical contraindication to the proposed anesthetic regimen, and chronic pain. On the day
before surgery, patients participated in a standard pre-operative evaluation and a brief structured interview (with
MKG) that included demographic information, psychiatric and substance use history and treatment. A urine
specimen for toxicology testing was obtained pre-surgically and analyzed using enzyme multiplied immunoassay
(EMIT) for the presence of methadone, opiates, cocaine,
amphetamines, barbiturates and benzodiazepines. Urine
samples were not collected post-surgically. Nursing staff
monitored patients (i.e. 24-hr observation) and veriﬁed
nicotine abstinence.
Treatment protocol
No analgesics or sedatives were used preoperatively,
consistent with the prevailing standard of care. All surgeries began between 0830 and 1130. Intra-operatively, patients had a lumbar epidural catheter placed and
were administered 2% lidocaine either alone or with 1:
200,000 epinephrine at the discretion of the Anesthesia
Care Team. If additional sedation or analgesia was needed, midazolam and ketamine were used. No opioids
were administered during the operative period. Patients
were informed that, during the postoperative recovery
period, they would receive an opioid analgesic via the
PCA device but were not told which drug, dose, or lockout interval would be used. They also received standardized pre-operative instructions about the use of the
PCA device.
Intravenous morphine PCA was initiated post-operatively using a commercially available PCA pump (CR Bard,
Inc, Murray Hill, NJ) in the Labor and Delivery suite
when the patient first complained of pain. No basal infusions were set so that the dosage would be entirely
determined by the patient. PCA was divided into two
phases: loading and maintenance. The loading phase
consisted of three consecutive 30-min periods. Initially,
the bolus was set at 3-mg morphine with a 6-min lockout (i.e. time-out) interval. If, upon questioning, the
patient did not report feeling “comfortable” at the end
of the 30-min period, the morphine bolus dose was increased to 4-mg for the next 30-min period and 5-mg
for the third 30-min period. Loading was terminated at
90 mins or when the patient reported feeling “comfortable”. The maintenance phase ensued upon completion
of loading and continued 24-hrs post-loading, with access to 1.5-mg morphine bolus doses on a 6-min lockout
schedule. We planned (a priori) a rescue analgesia protocol, such that continued pain reports by the patient
despite 7 or more boluses received during the previous
hour (reviewed by APM or MSH) resulted in a 1-mg increase in bolus size.
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Table 1. Mean (±SD) morphine requests, morphine use, and pain intensity reports.
Measure

CON (n=4)

NIC (n=3)

F(1,5) and P values

Loading
Morphine button presses

6.5

(3.7)

9.0

(7.6)

NS

Morphine use (total mg)

12.8

(7.5)

15.0

(10.8)

NS

Weight-adjusted morphine use (mg/kg)

0.16

(0.09)

0.17

(0.18)

NS

Infusions÷Requests

0.71

(0.26)

0.67

(0.28)

NS

McGill pain intensity, Pre-loading

2.75

(1.26)

4.33

(0.58)

NS

Post-loading

1.50

(1.00)

1.67

(0.58)

NS

CR

Maintenance
Morphine button presses (number during first 24 hr)

37.8

(9.9)

183.0

(49.6)

34.73

(0.002)

Morphine use (total mg during 24 hr)

49.5

(12.6)

136.0

(24.1)

39.12

(0.002)

Weight-adjusted morphine use (mg/kg/24 hr)

0.64

(0.28)

1.80

(0.39)

21.28

(0.006)

Infusions÷Requests

0.88

(0.09)

0.51

(0.11)

24.01

(0.005)

McGill pain intensity, 24 hr post-PCA

0.75

(0.50)

2.33

(0.58)

15.17

(0.02)

Measures

Objective clinical signs

Drug responding/use

Observer-rated signs of pain were grimacing (0 – no, 1 – yes),
moaning (0 – no, 1 – yes), out of bed (0 – no, 1 – yes), restless (0 – not at all, 1 – slightly, 2 – moderately, 3 – extremely), and mobile (0 – not at all, 1 – moves in bed, 2 – ambulatory with discomfort, 3 – ambulatory without discomfort).
Observer-rated drug side effects were vomiting (0 – no, 1 –
yes), scratching (0 – no, 1 – yes), sedated (0 – not at all, 1 –
slightly, 2 – moderately, 3 – extremely), and sweaty (0 – not
at all, 1 – slightly, 2 – moderately, 3 – extremely). Vital signs
measured were oxygen saturation, respiration rate, heart
rate, blood pressure, and oral temperature.

Two measures were recorded hourly from the infusion
pump during the PCA loading and 24-hr maintenance periods. Drug responding was deﬁned as the number of bolus
requests, regardless of success (i.e. including those during
the lockout interval). Drug use was the number of successful
bolus requests (i.e. morphine infusions), which was examined with and without adjustment for (pre-delivery) body
weight. Both measures were available through a printer connected to the PCA pump. A self-administration efﬁciency index was developed to characterize the effectiveness
with which patients responded for morphine. This derived
measure (a proportion ranging from 0 to 1) was deﬁned
as the total number of bolus infusions divided by the total
number of requests (button presses) during the 24-hr PCA
maintenance period.
Self-reports
The primary pain report measure was the McGill Pain
Questionnaire (MPQ) [7]. Although the MPQ has several factors, only the global pain severity score (0 – no pain,
1 – mild, 2 – discomforting, 3 – distressing, 4 – horrible,
5 – excruciating) was used due to the small sample size
(i.e. limited statistical power) and to emphasize clinical
signiﬁcance/utility. The total mood score of the 65-item
Proﬁle of Mood States (POMS) was used to assess the bipolar dimension of negative-positive mood [8]. PCA studies
that have assessed affect during recovery have found morphine to increase positive mood [9,10]. Drug effects were
measured using the Addiction Research Center Inventory
(ARCI), which is a 49-item scale that has two factors, euphoria (MBG scale) and sedation (PCAG scale), that were
of interest in the present study [11].

Performance
The Digit Symbol Substitution Test (DSST) was used to
measure psychomotor performance [12]. The patient attempted to manually transcribe a randomly presented series of nine different symbols that were associated with the
numbers 1 to 9 within a period of 90 sec. Following each
test, the number of attempted symbol-to-digit transcriptions
(speed) and the number correct (accuracy) were scored.
This measure has been used in PCA studies to assess potential cognitive-motor impairment [9,13].
Measurement timeline
On the day before surgery (pre-surgery baseline), the
POMS, ARCI and DSST were administered. Because these
measures were secondary and repeated measurements with
these instruments would have interfered with the primary
pain measures immediately after surgery, the only other
time that POMS, ARCI and DSST data were collected was
at 24 hrs after PCA maintenance. After surgery at the ﬁrst
complaint of pain (pre-loading baseline), subjective pain
(MPQ) and objective measures (pain behavior, side effects

CR257

Clinical Research

Med Sci Monit, 2005; 11(6): CR255-261

Table 2. Patient demographics.
Patient

Race

Age

Pre-Surgical
Weight (kg)

# Previous
C-sections

Group

2

W

21

71.8

1

NIC (1 pack cigs/day × 8 years)

4

W

34

83.6

2

NIC (1.5 packs cigs/day × 20 years)

10

W

26

72.7

1

NIC (1 pack cigs/day × 16 years)

3

W

29

104.5

1

CON

6

B

26

54.5

1

CON

7

W

35

85.5

2

CON

9

B

24

86.4

1

CON

and vital signs) were collected. Immediately after the morphine loading period but before PCA maintenance dosing began (post-loading time point), these same subjective
pain, and objective measures were collected. These signs/
symptoms were re-assessed at 2 and 4 hrs post-loading to
monitor progress. However, to avoid interfering further with
clinical care, no additional data were collected until 24 hrs
post-loading (all measures above).

Cesarean section and all delivered at a gestational age ranging from 38 to 40 weeks without major medical complications. At the time of their previous Cesarean section, all subjects received routine post-operative care including the use
of nurse-administered analgesia (opioids) rather than PCA.
In the CON group, one patient (#9) had a history of sickle
cell anemia and another (#3) had a history of insulin-dependent diabetes mellitus. No patient experienced any labor
pain prior to her elective Cesarean section surgery.

Data analysis
Morphine responding and morphine use data during the
loading period and the 24-hourly PCA maintenance period
were examined graphically using cumulative records. Total
24-hr morphine responding and total 24-hr morphine use
were analyzed separately using one-way Group (CON vs. NIC)
Analyses of Variance (ANOVAs). All other measures were analyzed using two-way mixed model ANOVAs, with Group as
the between subject factor and Time Points (which varied
across different measures [see description above]) as the
within subject factor. In general, Time-related effects were
not signiﬁcant at 2 hr and 4 hr post-loading (the only exceptions were MPQ global pain severity and objective pain
behaviors, which improved for both groups). Therefore, for
simplicity, these data are omitted from the text and Table 1,
and the focus is on pre- and post-loading and 24 hr post-PCA
maintenance results. T-tests were conducted to assess group
differences in pain severity scores at these time points. All
signiﬁcant effects are P<0.05 unless otherwise indicated.

RESULTS
Patient characteristics
Three patients were excluded from analysis. Patient #1 reported a history of psychiatric problems and past use of several illicit drugs. Patient #5 reported recent depression and
cocaine abuse, and patient #8 reported chronic heroin and
cocaine abuse and being in methadone maintenance. The
recent drug use reports by patients #5 and #8 were conﬁrmed by urine toxicology. The other seven subjects had
no illicit drugs/metabolites detected with urine toxicology.
The seven female participants who completed the protocol
(see Table 2) ranged in age from 21 to 35 years and reported 8 to 12 years of education. All had at least one previous
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Three patients reported using tobacco/nicotine (NIC) daily
in the 30 days prior to admission, and all three last smoked
on the day of hospital admission. Three of the other four
control patients (CON) denied ever having used tobacco/
nicotine and the other patient had smoked 1 to 2 cigarettes
per day for three years, but stopped one year prior to delivery. Four patients reported occasional moderate alcohol
use, but all denied alcohol use during their pregnancy. All
patients denied using most illicit drugs (heroin, cocaine,
benzodiazepines, barbiturates, hallucinogens and inhalants),
although two patients (#2, 6) reported brief experimental
use of marijuana only during adolescence. Three CON patients (#3, 7, 10) reported a history of diet pill (amphetamine) use that stopped 2–5 years prior to delivery. Three
participants (#3, 4, 10) reported daily caffeine use
Morphine responding/use
Figure 1 shows individual-patient cumulative records for morphine button pressing (upper panel) and consumption (lower panel) during the postoperative recovery period. Table 1
summarizes the group differences on the primary outcome
measures. Morphine button pressing and use were signiﬁcantly higher for NIC patients than CON patients only during the PCA maintenance but not during the loading period
(Table 1). This group difference became apparent between
1 and 6 hrs after starting PCA maintenance (Figure 1), at
a time that corresponds to about 30 hrs after these NIC patients last smoked cigarettes. When morphine use was adjusted for patients’ body-weight, this measure remained significantly higher for the NIC than the CON group (Table 1).
The self-administration efﬁciency index (# boluses ÷ # requests) was signiﬁcantly higher for the CON than the NIC
group; this reﬂects greater unproductive (i.e. lockout interval) button pressing by NIC than CON patients.

Med Sci Monit, 2005; 11(6): CR255-261

Marco AP et al – Morphine self-administration and tobacco abstinence

Number of button pressing requests for morphine

Morphine requests
300

#10
#4

200

#2
100
#3, 6, 7, 9

Drug and mood effects

0
0

4

8

12

16

20

24

Morphine consumption
#10
Weight-adjusted morphine intake (mg/kg)

niﬁcance is clear. Observer-rated restlessness (0–3 scale) was
greatest prior to loading (M ±SD =0.86±0.69), signiﬁcantly
decreased after loading (M=0.14±0.38), and remained lower
at the 24-hr time point (M=0.29±0.49), with no group (NIC
vs. CON) differences. No patient ever showed evidence of
moaning as a sign of pain. No patient was out of bed before
or after loading. At the 24-hr time point, all 3 NIC patients
were out of bed and 2 of the 4 CON patients were out of
bed. Participants were rated as being increasingly mobile
after surgery; mobility scores (0–3 scale) increased from
pre-loading (M=0.14±0.38) to post-loading (M=0.28±0.49)
to the 24-hr time point (M=0.86±0.69).

There were no signiﬁcant increases on any ARCI drug effect
or POMS mood scale for either group from the pre-surgery
assessment to the 24-hr time point. Thus, at the time points
measured, the groups did not differ in subjective mood, euphoria or sedation during PCA access.

2.0

1.5

#2
#4

1.0

#6

0.5

0.0

0

Vital signs

#7

There was no evidence of clinically signiﬁcant respiratory depression (deﬁned as breathing rates ≤10 breaths/min and/
or oxygen saturation ≤92%) for any participant nor were
there clinically signiﬁcant changes in other vital signs.

#3
#9

Psychomotor performance

4
8
12
16
20
24
Time (hours) after starting PCA maintenance phase

Figure 1. Individual patterns of morphine button pressing behavior
(upper panel) and body weight-adjusted morphine
consumption (lower panel) during 24-hr PCA. Numbers to
the right of each cumulative record indicate the consecutive
patient number (see Table 2). Patients #2, #4 and #10
reported current nicotine use (with minimum 24-hr
abstinence during hospitalization prior to PCA) and patients
#3, #6, #7 and #9 reported no current nicotine use.
Pain symptoms
Prior to loading with morphine, NIC patients reported somewhat higher global pain severity scores on the MPQ (“horrible” to “excruciating” range) than CON patients (“discomforting” to “distressing” range; see Table 1), but this
apparent group difference at baseline was not signiﬁcant.
Immediately after the loading period, MPQ pain severity
scores decreased to similar levels (“mild discomfort”) in
both groups (see Table 1). However, after 24 hrs of PCA
maintenance, pain severity was signiﬁcantly higher for NIC
than CON patients (see Table 1).
Objective pain behaviors
All seven participants were observed to grimace prior to the
loading period and none grimaced at any time point after
loading, indicating improved pain control; although this
measure could not be statistically analyzed for lack of between-subject variance at each time point, the clinical sig-

There were no signiﬁcant changes in the number of DSST
symbol-digit translations attempted or number correct for
either group during recovery.

DISCUSSION
Historically, medical professionals have not considered
the interaction between nicotine use/ abstinence and opioid-induced analgesia. Patients with a history of smoking
have been reported to use more PCA morphine than nonsmokers in retrospective analyses [4,14]. In this prospective
study, we observed that post-operative patients with current
(≥1 pack) daily nicotine use (NIC), but abstaining during
hospitalization, demonstrated signiﬁcantly greater morphine
responding and consumption than patients without nicotine use (CON). Although the schedule of drug availability can inﬂuence patterns of self-administration, the dosing
schedule in this study represents a clinically relevant practice pattern, and no patient used the maximum available
amount of morphine.
One potential explanation for the group difference in morphine responding/use is that NIC patients experienced
greater pain severity (i.e., were hyperalgesic) from surgery
and, thus, self-administered morphine more frequently to
achieve analgesia. If so, then greater pain reports would be
expected to precede morphine responding. Unfortunately,
the present study was not designed to address the cyclic interaction of pain reporting/morphine use; however, NIC
patients showed a non-signiﬁcant tendency to report more
pain before loading (this trend was neutralized by morphine
loading), and did report signiﬁcantly greater pain at 24 hr
post-PCA. While these data could suggest that the pain experienced by NIC patients was partially unrelieved despite
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greater PCA utilization, further research is needed to address this issue.
A second potential explanation for the group difference in
morphine responding/use is that NIC patients might have
experienced nicotine abstinence symptoms (e.g. negative
mood) that prompted greater morphine self-administration.
In laboratory animals exposed to nicotine, abstinence enhances nociceptive transmission [5,6]. Further, precipitated
nicotine abstinence signs in an animal model can be attenuated by morphine [15,16]. Taken together, this evidence
implies that nicotine abstinence may modulate functioning
of the endogenous opioid system. Therefore, in the present
study, it is possible that NIC patients may have self-administered higher doses of morphine to relieve their nicotine
abstinence symptoms. One limitation of this study, however, is that nicotine abstinence symptoms were not directly
measured with questionnaires. The POMS data, however, did
not support the hypothesis that negative mood was higher
in the NIC group. This remains an important issue for understanding the mechanism(s) underlying these group differences in analgesic utilization. Regardless, the increased
morphine consumption for the recently nicotine-abstinent
patients suggests that clinicians should consider providing
this group more liberal access to opioid PCA.
A third possible explanation for the group difference in morphine responding/use might be that NIC patients (due to
their habitual drug use and possible neurochemical alterations) sought positive mood change (e.g. euphoria) rather
than relief of aversive withdrawal symptoms. Again, however, the POMS data and the ARCI MBG (euphoria) scale did
not show that the groups differed in mood. Furthermore,
the NIC patients were not more sedated, cognitively impaired, nor were their vital signs altered as a result of their
greater morphine consumption. This indicates that a greater clinical allowance for morphine use in NIC patients can
be achieved with a sufﬁcient safety margin.
Several factors that might confound the present results were
controlled. The individual differences observed here are obviously not gender-related. They are also unlikely to be explained by differences in the extent of surgical incision, preor intra-operative anesthetic regimens (which were highly
constrained and precluded opioids), labor pain (absent in
all cases), medical complications, or diurnal variation (all
surgery and recovery periods were on the same schedule).
It is possible the groups differed in their comprehension
of PCA pump operation and this could account for the observed differences in button pressing behavior. Future studies should test for comprehension to minimize such effects.
Factors that limit conclusions from this study include the
small sample size and potential bias in the group demographics (although we found no disparities in self-reported psychiatric or drug use histories). Difﬁculty in achieving comfort during the loading period could discourage
patients from utilizing the PCA device during the maintenance period. However, we do not believe this occurred because the groups did not signiﬁcantly differ in morphine
use or McGill pain severity scores during the loading period, yet they differed signiﬁcantly during the maintenance
period. Overall, the ability to control (or minimize the inﬂuence of) these factors will increase power to detect statistically signiﬁcant differences.
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One surprising aspect of the results is that robust differences were observed between small groups of patients differing in nicotine use/abstinence. Although these preliminary
results must be interpreted cautiously because of the small
sample size, they demonstrate the differences between nicotine naive and nicotine-abstaining subjects in their need
for narcotic analgesia. Also, this study suggests a methodology that can be used to analyze this behavior in other patient populations.

CONCLUSIONS
The present study establishes that nicotine abstinence
results in clinically and statistically different morphine
requests/utilization compared to non-smokers. The number
of bolus requests as well as the amount of drug (relative to
body weight) is a useful measure to assess patient’s self-perception of pain. Other assessment procedures in this study
– drug effects (e.g, euphoria), graded pain response (e.g.
after rest, paced breathing, and coughing), and objective
indices of pain behavior (e.g. mobility, restlessness) – provide functional measures of medication effectiveness and
recovery that can be helpful to physicians and nurses. The
next useful steps should be to (1) determine whether differential PCA response among tobacco using patients is due to
their inherently greater pain sensitivity, nicotine withdrawal
symptoms (due to abstinence during hospitalization), greater drug-seeking behavior, or some interaction of these factors; and (2) develop a clinical strategy for managing postoperative pain in this patient subgroup.
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